{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:36:04Z","timestamp":1795084564187,"version":"4.10.2"},"reference-count":108,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1097\/aog.0000000000001708","type":"journal-article","created":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T05:26:20Z","timestamp":1474608380000},"page":"e111-e130","source":"Crossref","is-referenced-by-count":117,"title":["ACOG"],"prefix":"10.1097","volume":"128","member":"276","reference":[{"key":"R2-20210203","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"R4-20210203","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1097-0215(19970410)71:2<159::AID-IJC6>3.0.CO;2-#","article-title":"International incidence rates of invasive cervical cancer before cytological screening","volume":"71","author":"Gustafsson","year":"1997","journal-title":"Int J Cancer"},{"key":"R5-20210203","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1023\/A:1018435522475","article-title":"International incidence rates of invasive cervical cancer after introduction of cytological screening","volume":"8","author":"Gustafsson","year":"1997","journal-title":"Cancer Causes Control"},{"key":"R6-20210203","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3322\/caac.21139","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. ACS-ASCCP-ASCP Cervical Cancer Guideline Committee","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"R7-20210203","doi-asserted-by":"crossref","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. U.S. Preventive Services Task Force [published erratum appears in Ann Intern Med 2013;158:852]","volume":"156","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"R8-20210203","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/AOG.0000000000000669","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"125","author":"Huh","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R9-20210203","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/(SICI)1097-0142(20000515)88:10<2283::AID-CNCR12>3.0.CO;2-D","article-title":"Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan","volume":"88","author":"Sung","year":"2000","journal-title":"Cancer"},{"key":"R10-20210203","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/jnci\/dji115","article-title":"Cervical cancer in women with comprehensive health care access: attributable factors in the screening process","volume":"97","author":"Leyden","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R13-20210203","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ypmed.2007.06.007","article-title":"Process of care fail- ures in invasive cervical cancer: systematic review and meta-analysis","volume":"45","author":"Spence","year":"2007","journal-title":"Prev Med"},{"key":"R14-20210203","first-page":"464","article-title":"Cancer Screening Test Use \u2014 United States, 2013","volume":"64","author":"Sabatino","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R15-20210203","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJMp020178","article-title":"Adding a test for human papillomavirus DNA to cervical-cancer screening","volume":"348","author":"Wright","year":"2003","journal-title":"N Engl J Med"},{"key":"R16-20210203","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/oxfordjournals.jncimonographs.a003476","article-title":"Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia","volume":"31","author":"Schiffman","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"key":"R17-20210203","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2569","article-title":"Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. Proyecto Epidemiologico Guanacaste (PEG) Group","volume":"339","author":"Castle","year":"2009","journal-title":"BMJ"},{"key":"R18-20210203","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/jnci\/djq356","article-title":"Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence","volume":"102","author":"Kjaer","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"R19-20210203","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Retrospective International Survey and HPV Time Trends Study Group","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"R20-20210203","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn510","article-title":"Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States","volume":"101","author":"Wheeler","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"R21-20210203","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/oxfordjournals.jncimonographs.a003479","article-title":"Chapter 1: Human papillomavirus and cervical cancer\u2013burden and assessment of causality","volume":"31","author":"Bosch","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"key":"R22-20210203","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1158\/1055-9965.EPI-09-0763","article-title":"Relationship between cigarette smoking and human papilloma virus types 16 and 18 DNA load","volume":"18","author":"Xi","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"suppl 3","key":"R23-20210203","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.vaccine.2006.06.018","article-title":"Chapter 5: Updating the natural history of HPV and anogenital cancer","volume":"24","author":"Moscicki","year":"2006","journal-title":"Vaccine"},{"key":"R24-20210203","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"key":"R25-20210203","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1054\/bjoc.2001.1845","article-title":"Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women","volume":"84","author":"Clavel","year":"2001","journal-title":"Br J Cancer"},{"key":"R26-20210203","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.288.14.1749","article-title":"Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral","volume":"288","author":"Kulasingam","year":"2002","journal-title":"JAMA"},{"key":"R27-20210203","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/AOG.0b013e3181996ffa","article-title":"Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting","volume":"113","author":"Castle","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R28-20210203","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/516784","article-title":"A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. ALTS Group","volume":"195","author":"Plummer","year":"2007","journal-title":"J Infect Dis"},{"key":"R29-20210203","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. Proyecto Epidemiologico Guanacaste Group","volume":"100","author":"Rodriguez","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R30-20210203","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(00)04956-4","article-title":"Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study","volume":"357","author":"Woodman","year":"2001","journal-title":"Lancet"},{"key":"R31-20210203","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/aje\/kwf180","article-title":"Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students [published erratum appears in Am J Epidemiol","volume":"157","author":"Winer","year":"2003","journal-title":"Am J Epidemiol"},{"key":"R32-20210203","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1158\/1055-9965.EPI-06-0846","article-title":"Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives","volume":"16","author":"Insinga","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R33-20210203","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"N Engl J Med"},{"key":"R34-20210203","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1086\/426867","article-title":"A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women","volume":"191","author":"Brown","year":"2005","journal-title":"J Infect Dis"},{"key":"R35-20210203","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0022-3476(98)70445-7","article-title":"The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women","volume":"132","author":"Moscicki","year":"1998","journal-title":"J Pediatr"},{"key":"R36-20210203","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/S0140-6736(04)17354-6","article-title":"Regression of low-grade squamous intra-epithelial lesions in young women","volume":"364","author":"Moscicki","year":"2004","journal-title":"Lancet"},{"key":"R37-20210203","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajog.2007.03.029","article-title":"Adolescent cervical dysplasia: histologic evaluation, treatment, and outcomes","volume":"197","author":"Moore","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"R38-20210203","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jpag.2007.04.012","article-title":"Management of cervical intraepithelial neoplasia 2 in adolescent and young women","volume":"20","author":"Fuchs","year":"2007","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R39-20210203","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/jnci\/djr283","article-title":"Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer. CBCSP-HPV Study Group","volume":"103","author":"Chen","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"R40-20210203","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. 2012 ASCCP Consensus Guidelines Conference [published erratum appears in J Low Genit Tract Dis 2013;17:367]","volume":"17","author":"Massad","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"R41-20210203","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1309\/PT3PNC1QL2F4D2VL","article-title":"The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report","volume":"127","author":"Castle","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"R42-20210203","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/pgp.0b013e31805152ab","article-title":"CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples","volume":"26","author":"Carreon","year":"2007","journal-title":"Int J Gynecol Pathol"},{"key":"R43-20210203","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/LGT.0b013e31825c31dd","article-title":"The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Members of LAST Project Work Groups [published erratum appears in J Low Genit Tract Dis 2013;17:368]","volume":"16","author":"Darragh","year":"2012","journal-title":"J Low Genit Tract Dis"},{"key":"R44-20210203","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol"},{"key":"R45-20210203","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejogrb.2014.11.006","article-title":"Does lubrication of the vaginal speculum reduce pain during a gynecologic oncology examination?","volume":"184","author":"Gungorduk","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R46-20210203","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00404-013-3047-x","article-title":"The role of gel application in decreasing pain during speculum examination and its effects on papanicolaou smear results","volume":"289","author":"Simavli","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"R47-20210203","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3122\/jabfm.2012.06.120021","article-title":"Association of speculum lubrication with pain and Papanicolaou test accuracy","volume":"25","author":"Uygur","year":"2012","journal-title":"J Am Board Fam Med"},{"key":"R48-20210203","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/AOG.0b013e3182426275","article-title":"Effect of lubricating gel on patient comfort during vaginal speculum examination: a randomized controlled trial","volume":"119","author":"Hill","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R49-20210203","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/LGT.0b013e3181ab4584","article-title":"Lubricant, mucus, and other contaminant materials as a potential source of interpretation errors in ThinPrep cervical cytology","volume":"14","author":"AbdullGaffar","year":"2010","journal-title":"J Low Genit Tract Dis"},{"key":"R50-20210203","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1159\/000325617","article-title":"Effects of gel lubricant on cervical cytology","volume":"52","author":"Charoenkwan","year":"2008","journal-title":"Acta Cytol"},{"key":"R51-20210203","first-page":"889","article-title":"The effect of vaginal speculum lubrication on the rate of unsatisfactory cervical cytology diagnosis","volume":"100","author":"Amies","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R52-20210203","first-page":"887","article-title":"Lubrication of the vaginal introitus and speculum does not affect Papanicolaou smears","volume":"100","author":"Harer","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R53-20210203","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3122\/jabfm.19.4.340","article-title":"Does gel affect cytology or comfort in the screening papanicolaou smear?","volume":"19","author":"Gilson","year":"2006","journal-title":"J Am Board Fam Med"},{"key":"R54-20210203","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.contraception.2005.01.004","article-title":"Vaginal speculum lubrication and its effects on cervical cytology and microbiology","volume":"72","author":"Griffith","year":"2005","journal-title":"Contraception"},{"key":"R55-20210203","first-page":"309","article-title":"Papanicolaou tests: does lubricant reduce the quality or adequacy?","volume":"57","author":"Allan","year":"2011","journal-title":"Can Fam Physician"},{"key":"R56-20210203","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.AOG.0000296488.85807.b3","article-title":"Liquid compared with conventional cervical cytology: a systematic review and meta- analysis","volume":"111","author":"Arbyn","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R57-20210203","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1001\/jama.2009.1569","article-title":"Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial [published erratum appears in JAMA 2009;302:2322]","volume":"302","author":"Siebers","year":"2009","journal-title":"JAMA"},{"key":"R59-20210203","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1158\/0008-5472.CAN-09-4179","article-title":"A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia","volume":"70","author":"Schiffman","year":"2010","journal-title":"Cancer Res"},{"key":"R60-20210203","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1309\/AJCPRI8XPQUEAA3K","article-title":"Special commentary: patient safety and the next generation of HPV DNA tests","volume":"134","author":"Kinney","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"R61-20210203","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"Meijer","year":"2009","journal-title":"Int J Cancer"},{"key":"R62-20210203","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1309\/RNF3C01JKADQCLKP","article-title":"The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays. American Society for Colposcopy and Cervical Pathology","volume":"127","author":"Stoler","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"R63-20210203","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(11)60551-5","article-title":"Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study","volume":"377","author":"Brotherton","year":"2011","journal-title":"Lancet"},{"key":"R64-20210203","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/597307","article-title":"The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years","volume":"199","author":"Brown","year":"2009","journal-title":"J Infect Dis"},{"key":"R65-20210203","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1586\/14760584.2014.963561","article-title":"The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon","volume":"13","author":"Chatterjee","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"R66-20210203","first-page":"300","article-title":"Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. Centers for Disease Control and Prevention (CDC)","volume":"64","author":"Petrosky","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R67-20210203","first-page":"e38","article-title":"Committee Opinion No. 641. American College of Obstetricians and Gyne-cologists","volume":"126","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R69-20210203","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3201\/eid1301.060438","article-title":"Model for assessing human papillomavirus vaccination strategies","volume":"13","author":"Elbasha","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"R70-20210203","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1001\/archinte.168.17.1881","article-title":"Trade-offs in cervical cancer prevention: balancing benefits and risks","volume":"168","author":"Stout","year":"2008","journal-title":"Arch Intern Med"},{"key":"R71-20210203","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1177\/0272989X07302128","article-title":"Abnormal outcomes following cervical cancer screening: event duration and health utility loss","volume":"27","author":"Insinga","year":"2007","journal-title":"Med Decis Making"},{"key":"R72-20210203","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/sj.bjc.6602411","article-title":"The psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: 6-month follow-up","volume":"92","author":"Maissi","year":"2005","journal-title":"Br J Cancer"},{"key":"R73-20210203","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/AOG.0000000000000632","article-title":"Increased cervical cancer risk associated with screening at longer intervals","volume":"125","author":"Kinney","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R74-20210203","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s10552-009-9317-z","article-title":"Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity","volume":"20","author":"Barnholtz-Sloan","year":"2009","journal-title":"Cancer Causes Control"},{"key":"R75-20210203","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/LGT.0b013e3181cec411","article-title":"Practice improvement in cervical screening and management (PICSM): symposium on management of cervical abnormalities in adolescents and young women","volume":"14","author":"Moscicki","year":"2010","journal-title":"J Low Genit Tract Dis"},{"key":"R76-20210203","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1002\/cncr.23756","article-title":"Burden of cervical cancer in the United States, 1998-2003","volume":"113","author":"Watson","year":"2008","journal-title":"Cancer"},{"key":"R77-20210203","volume":"339","author":"Sasieni","year":"2009","journal-title":"Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data [published erratum appears in BMJ"},{"key":"R78-20210203","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/524875","article-title":"Risk of female human papillomavirus acquisition associated with first male sex partner","volume":"197","author":"Winer","year":"2008","journal-title":"J Infect Dis"},{"key":"R79-20210203","first-page":"1378","article-title":"Committee Opinion No. 582. American College of Obstetricians and Gynecologists","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R80-20210203","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.AOG.0000165822.29451.54","article-title":"Cervical dysplasia in adolescents","volume":"106","author":"Wright","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R81-20210203","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","article-title":"Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis","volume":"367","author":"Kyrgiou","year":"2006","journal-title":"Lancet"},{"key":"R82-20210203","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1471-0528.2011.02944.x","article-title":"The risk of preterm birth following treatment for precancerous changes in the cervix: a systematic review and meta-analysis","volume":"118","author":"Bruinsma","year":"2011","journal-title":"BJOG"},{"key":"R83-20210203","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/AOG.0000000000000174","article-title":"Loop electrosurgical excision procedure and risk of preterm birth: a systematic review and meta-analysis","volume":"123","author":"Conner","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R84-20210203","first-page":"1143","article-title":"Committee Opinion No. 598. American College of Obstetricians and Gyne-cologists","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"suppl 3","key":"R85-20210203","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.vaccine.2006.05.117","article-title":"Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses","volume":"24","author":"Arbyn","year":"2006","journal-title":"Vaccine"},{"key":"R87-20210203","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/jnci\/djj209","article-title":"Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. New Technologies for Cervical Cancer Working Group","volume":"98","author":"Ronco","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R88-20210203","doi-asserted-by":"crossref","first-page":"a1754","DOI":"10.1136\/bmj.a1754","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening. Joint European Cohort Study","volume":"337","author":"Dillner","year":"2008","journal-title":"BMJ"},{"key":"R89-20210203","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1097\/LGT.0b013e318285423c","article-title":"Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines","volume":"17","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"R90-20210203","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","article-title":"Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial","volume":"13","author":"Rijkaart","year":"2012","journal-title":"Lancet Oncol"},{"key":"R91-20210203","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. New Technologies for Cervical Cancer screening (NTCC) Working Group","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"key":"R92-20210203","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer [published erratum appears in N Engl J Med 2008;359:1637]","volume":"357","author":"Naucler","year":"2007","journal-title":"N Engl J Med"},{"key":"R93-20210203","first-page":"885","article-title":"collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. International Collaboration of Epidemiological Studies of Cervical Cancer [published erratum appears in Int J Cancer 2007; 120:2525]","volume":"120","year":"2007","journal-title":"Int J Cancer"},{"key":"R94-20210203","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","article-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice [published erratum appears in Lancet Oncol 2011;12:722]","volume":"12","author":"Katki","year":"2011","journal-title":"Lancet Oncol"},{"key":"R95-20210203","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c1804","article-title":"Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme","volume":"340","author":"Anttila","year":"2010","journal-title":"BMJ"},{"key":"R96-20210203","first-page":"421","article-title":"Committee Opinion No. 534. American College of Obstetricians and Gynecologists","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R98-20210203","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/sj.bjc.6600974","article-title":"Benefit of cervical screening at different ages: evidence from the UK audit of screening histories","volume":"89","author":"Sasieni","year":"2003","journal-title":"Br J Cancer"},{"key":"R99-20210203","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/bmj.293.6548.659","article-title":"duration of low risk after negative results of cervical cytology and its implication for screening policies. IARC Working Group on evaluation of cervical cancer screening programmes","volume":"293","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R100-20210203","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00006250-200008000-00012","article-title":"Frequency of cervical smear abnormalities within 3 years of normal cytology","volume":"96","author":"Sawaya","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R101-20210203","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/1097-0142(19870901)60:5<1117::AID-CNCR2820600533>3.0.CO;2-H","article-title":"The frequency of cervical cancer screening. Comparison of a mathematical model with empirical data","volume":"60","author":"Eddy","year":"1987","journal-title":"Cancer"},{"key":"R102-20210203","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00006250-200305000-00043","article-title":"Screening interval and risk of invasive squamous cell cervical cancer","volume":"101","author":"Miller","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R104-20210203","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1046\/j.1532-5415.2001.4911243.x","article-title":"Advancing age and cervical cancer screening and prognosis","volume":"49","author":"Sawaya","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"R105-20210203","doi-asserted-by":"crossref","first-page":"942","DOI":"10.7326\/0003-4819-133-12-200012190-00009","article-title":"The positive predictive value of cervical smears in previously screened postmenopausal women: the Heart and Estrogen\/progestin Replacement Study (HERS)","volume":"133","author":"Sawaya","year":"2000","journal-title":"Ann Intern Med"},{"key":"R106-20210203","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/j.1471-0528.2006.01099.x","article-title":"Vaginal vault smears after hysterectomy for reasons other than malignancy: a systematic review of the literature","volume":"113","author":"Stokes-Lampard","year":"2006","journal-title":"BJOG"},{"key":"R107-20210203","first-page":"188","article-title":"Vaginal intraepithelial neoplasia (VAIN) following hysterectomy in patients treated for carcinoma in situ of the cervix","volume":"18","author":"Kalogirou","year":"1997","journal-title":"Eur J Gynaecol Oncol"},{"key":"R108-20210203","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0002-9378(97)80018-X","article-title":"Vaginal intraepithelial neoplasia: risk factors for persistence, recurrence, and invasion and its management","volume":"176","author":"Sillman","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"R110-20210203","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R111-20210203","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1097\/01.AOG.0000438960.31355.9e","article-title":"Management of abnormal cervical cancer screening test results and cervical cancer precursors. Practice Bulletin No. 140. American College of Obstetricians and Gynecologists","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R112-20210203","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/LGT.0b013e3182854253","article-title":"Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results","volume":"17","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"R113-20210203","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"Khan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R114-20210203","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1309\/AJCPTUS5EXAS6DKZ","article-title":"Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results. ATHENA (Addressing THE Need for Advanced HPV Diagnostics) Study Group","volume":"136","author":"Wright","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"R115-20210203","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1470-2045(11)70286-8","article-title":"Overall efficacy of HPV-16\/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. HPV PATRICIA Study Group [published erratum appears in Lancet Oncol 2012;13:e1]","volume":"13","author":"Lehtinen","year":"2012","journal-title":"Lancet Oncol"},{"key":"R116-20210203","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. FUTURE II Study Group","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"key":"R117-20210203","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1542\/peds.2011-0950","article-title":"Human papillomavirus vaccination series initiation and completion, 2008-2009 [published erratum appears in Pediatrics 2012;130:166\u20138]","volume":"128","author":"Dorell","year":"2011","journal-title":"Pediatrics"},{"key":"R119-20210203","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/ijc.21604","article-title":"Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia","volume":"118","author":"Soutter","year":"2006","journal-title":"Int J Cancer"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201610000-00058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T15:52:44Z","timestamp":1689090764000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201610000-00058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":108,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000001708","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}